EHBBVI INK has a total of 34 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SHANGHAI HENGRUI PHARM CO LTD, ABBVIE DEUTSCHLAND and IBFB GMBH PRIVATES INST FUER B.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 34 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Sauehrs Ehndrju Dzh | 9 |
#2 | Kheksamer Laura | 7 |
#3 | Din Khun | 6 |
#4 | Sallivan Dzherard M | 6 |
#5 | Uehndt Majkl D | 6 |
#6 | Ehlmor Stiven V | 6 |
#7 | Tao Chzhi-Fu | 6 |
#8 | Van Silu | 5 |
#9 | Khsiekh Chung-Ming | 5 |
#10 | Sun Sjaokhun | 5 |
Publication | Filing date | Title |
---|---|---|
RU2518340C2 | Recombinant expression vector elements (reves) to enhance expression of recombinant proteins in host cells |